Ontology highlight
ABSTRACT:
SUBMITTER: Tang Y
PROVIDER: S-EPMC3400842 | biostudies-other | 2012 Aug
REPOSITORIES: biostudies-other
Tang Yong Y Hamed Hossein A HA Poklepovic Andrew A Dai Yun Y Grant Steven S Dent Paul P
Molecular pharmacology 20120517 2
The present studies sought to define whether checkpoint kinase 1 (CHK1) inhibitors and poly(ADP-ribose) polymerase 1 (PARP1) inhibitors interact in vitro and in vivo to kill breast cancer cells. PARP1 and CHK1 inhibitors interacted to kill estrogen receptor (ER)+, ER+ fulvestrant-resistant, HER2+, or triple-negative mammary carcinoma cells in a manner that was not apparently affected by phosphatase and tensin homolog deleted on chromosome 10 functional status. Expression of dominant-negative CHK ...[more]